The achievement of a noble mission that is highly technical depends on the caliber of the people involved in the project. Here are the people involved in Metabolic Restoration Therapy.
Dr. Lakey has had a long interest and research focus in diabetes and islet transplantation. Dr. Lakey graduated from the University of Alberta at Edmonton (B.Sc., M.Sc., Ph.D.) and received postsecondary training in Indianapolis (IUPUI, Perdue) and Seattle (NWTC, UW) before returning to establish his research program at the University of Alberta. Dr. Lakey is currently an Associate Professor of Surgery and Biomedical Engineering, and Director of Research and the Clinical Islet Program in the Department of Surgery at the University of California, Irvine.
Currently director of an Obesity and Diabetes clinical program in Southern California with a strong nutritional background and interest in changing the way diabetics and obese people eat. Past CEO and president of hCell Technology a biotech company growing media and beta cells for pancreatic islet cell transplantation. Prior to that he was CEO and president of a large Multispecialty Clinic in Nevada. Dr. Knutzen has been at the forefront of both biotechnology and nutritional advances in both obesity and diabetes management advances.
Uday P. Singh is the Director of Business Development for India & Asia for MRTL. His distinguished career includes public service and business. In 1993, as a result of mediation efforts in resolving social development issues between India and Nepal, the Government of India awarded Mr. Singh the Gem of India Award and the Hind Gaurav Award. Singh is responsible for MRTL business development in India and Southeast Asia.